Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.

@article{Dahl1999SerumHI,
  title={Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentration.},
  author={Inger Marie S. Dahl and Ingemar Turesson and Erik Holmberg and Karl Lilja},
  journal={Blood},
  year={1999},
  volume={93 12},
  pages={4144-8}
}
Serum from 386 myeloma patients were analyzed for serum hyaluronan (HYA) at diagnosis. Median age was 68 years (range, 32 to 87 years). The distribution of Ig classes was typical (58% IgG, 21% IgA, 1% IgD, and 20% light chain disease). The patients comprised 58% in stage III, 33% in stage II, and 9% in stage I. The majority (82%) had HYA values within an intermediate range (10 to 120 micrograms/L), 13% had high values (>120 micrograms/L), and 5% had abnormally low values (0 to 9 micrograms/L… CONTINUE READING